Can MASCC and CISNE scores predict delays of lung cancer chemotherapy after febrile neutropenia?

Abstract Background Febrile neutropenia (FN) during cancer chemotherapy can lead to morbidity and mortality. The Multinational Association of Supportive Care in Cancer (MASCC) and clinical index of stable febrile neutropenia (CISNE) scores have been widely used to predict the risk of severe medical...

Full description

Bibliographic Details
Main Authors: Yoshitaka Ono, Naoki Hayama, Shigeaki Hattori, Yoko Ito, Tsuyoshi Oguma, Fumio Sakamaki, Koichiro Asano
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:Thoracic Cancer
Subjects:
Online Access:https://doi.org/10.1111/1759-7714.14720